Read + Share
Amedeo Smart
Independent Medical Education
Hayne D, Ong K, Swarbrick N, McCombie SP, et al. The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancer. BJU Int 2024 Mar 12. doi: 10.1111/bju.16325.PMID: 38469652
Email
LinkedIn
Facebook
Twitter
Privacy Policy